Coya Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Coya Therapeutics, Inc. (COYA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents38.3432.635.934.348.72
Cash & Short-Term Investments38.3432.635.934.348.72
Accounts Receivable0.737.500.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets5.241.071.250.240.03
Total Current Assets44.3141.207.184.588.75
Non-Current Assets
Property, Plant & Equipment (Net)0.040.070.090.120.00
Other Non-Current Assets0.007.500.000.000.00
Total Non-Current Assets0.040.071.210.210.00
Total Assets44.3541.268.404.798.75
Current Liabilities
Accounts Payable1.591.163.820.860.45
Accrued Liabilities1.392.252.010.290.00
Deferred Revenue0.850.920.000.000.00
Other Current Liabilities1.390.570.000.000.00
Total Current Liabilities3.825.053.821.150.45
Non-Current Liabilities
Long-Term Debt0.000.0012.970.000.00
Other Non-Current Liabilities0.001.500.000.000.00
Total Non-Current Liabilities0.950.5712.970.000.00
Total Liabilities4.775.6316.791.150.45
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-40.74-25.86-17.87-5.62-0.73
Accumulated Other Comprehensive Income0.00-0.010.000.000.00
Additional Paid-in Capital80.3161.500.680.470.00
Shares Outstanding16.7114.419.689.680.00
Total Stockholders' Equity39.5835.64-8.393.648.30
Total Liabilities & Equity44.3541.268.404.790.00